Tucaxen 150 mg tablet ( tucatinib)

Tucaxen 150 mg (Tucatinib) - Targeted Therapy for HER2+ Breast Cancer

Tucaxen 150 mg (Tucatinib) is an advanced oral oncology medication used in the targeted treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. It is a kinase inhibitor designed to work in combination with other medications to slow tumor progression, even in advanced stages.

This medication is manufactured by Everest Pharmaceuticals Ltd., a leading pharmaceutical company in Bangladesh, and is supplied globally by Mediaid Pharmacy. We are committed to providing patients and healthcare professionals worldwide with access to genuine, high-quality cancer treatments. This product is available for Export Only.

What is Tucaxen 150 mg (Tucatinib)?

Tucaxen contains the active ingredient Tucatinib, which is a tyrosine kinase inhibitor (TKI) highly specific to HER2. In HER2-positive breast cancer, the HER2 protein is overexpressed, causing cancer cells to grow and divide rapidly.

Tucaxen works by blocking the chemical signals generated by the HER2 protein. By inhibiting these signals, it stops the cancer cells from growing. Notably, Tucaxen is small enough to cross the blood-brain barrier, making it effective in treating cancer that has spread to the brain (brain metastases).

Indications for Use

Tucaxen 150 mg is indicated for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer.

It is typically prescribed in combination with trastuzumab and capecitabine for patients who have received one or more prior anti-HER2-based regimens in the metastatic setting.

Dosage & Administration

Tucaxen is available as a 150 mg tablet. The treatment regimen usually involves taking the medication orally twice a day.

• Standard Recommended Dose: 300 mg taken orally twice daily. This typically means taking two 150 mg tablets in the morning and two 150 mg tablets in the evening.
• Administration: Tucaxen can be taken with or without food. Tablets should be swallowed whole and not chewed, crushed, or split.
• Consistency: Doses should be taken approximately 12 hours apart at the same time every day.

Always follow the specific dosage instructions and combination schedule provided by your qualified oncologist.

Manufacturer – Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a renowned manufacturer in the pharmaceutical industry, known for its high-tech production of specialized oncology drugs. With facilities that comply with international Good Manufacturing Practices (GMP), Everest ensures that Tucaxen is produced to the highest standards of safety, purity, and potency.

Supplier – Mediaid Pharmacy

Mediaid Pharmacy is your trusted global supplier and distributor of specialized oncology medicines, including Tucaxen 150 mg. We are dedicated to bridging the gap in global healthcare by ensuring patients have access to essential medications.

Mediaid Pharmacy is known for:

• Worldwide Shipping: We securely ship "Export Only" medications to patients, pharmacies, and hospitals across the globe.
• Guaranteed Authenticity: We source Tucaxen directly from Everest Pharmaceuticals to ensure you receive 100% genuine products.
• Patient-Centric Service: Our professional team provides dedicated support and ensures a seamless, confidential ordering process.
• Competitive Pricing: We strive to offer affordable solutions for advanced cancer care.

Why Choose Tucaxen 150 mg from Mediaid Pharmacy?

• Targeted Efficacy: Specifically targets HER2 protein with high selectivity.
• Brain Metastasis Treatment: One of the few drugs effective for HER2+ cancer that has spread to the brain.
• High-Quality Manufacturing: Produced by Everest Pharmaceuticals under strict quality control.
• Global Availability: Distributed efficiently by Mediaid Pharmacy with reliable shipping options.

Frequently Asked Questions (FAQs)

Q: Can I take Tucaxen with food?
A: Yes, Tucaxen tablets can be taken with or without food.

Q: How many tablets are in a box?
A: This pack of Tucaxen 150 mg contains 30 tablets.

Q: Is this medication taken alone?
A: Tucaxen is typically used in combination with two other medicines: trastuzumab and capecitabine. Always follow your doctor's treatment plan.

Conclusion

Tucaxen 150 mg (Tucatinib) is a breakthrough therapy for patients with advanced HER2-positive breast cancer, particularly those with brain metastases. Manufactured by Everest Pharmaceuticals and supplied by Mediaid Pharmacy, it provides a high-quality and accessible treatment option for patients worldwide.

Contact Us to Order or Inquire

For the latest pricing, bulk orders, or to speak with our pharmacy team about Tucaxen 150 mg (Tucatinib), please contact us. We are available 24/7 to support your healthcare needs.

WhatsApp/WeChat: +8801773428128